Pediatric brain tumors often begin with nonspecific symptoms—some physical, some behavioral—that can be attributed to internal medicine or psychiatric differential diagnoses, thereby presenting typical diagnostic pitfalls. Clinical case examples from the past and present—involving behavioral changes, episodic movement disorders, persistent headaches, or supposedly functional symptoms—demonstrate how quickly such presentations can be misinterpreted. Reliable classification requires combining basic clinical diagnostics—systematic follow-up, assessment of symptom persistence, and neurological examination—with interdisciplinary knowledge from neurology, psychiatry, and internal medicine. Modern imaging and molecular techniques increase diagnostic precision; however, they do not replace conventional clinical diagnostics but rather complement them, as innovative techniques should always build upon a careful initial clinical evaluation.
Autoren
- Roswitha Kuffner
- Dr. oec. Odile Schwarz-Herion
Publikation
- InFo ONKOLOGIE & HÄMATOLOGIE
Related Topics
- AI-Assisted Imaging for Pediatric Brain Tumors
- Cerebrospinal Fluid-Based Diagnostics for CNS Tumors in Children
- cfDNA Methylation Analysis in Cerebrospinal Fluid for Pediatric Brain Tumors
- Clinical warning signs of intracranial space-occupying lesions
- Confusion Between Migraines and Brain Tumors in Children
- Conventional Diagnostics as the Basis for Treatment Decisions
- Diagnosis of Pediatric Brain Tumors in Riedstadt
- Diagnosis of Pilocystic Astrocytoma
- Differential Diagnosis of Neuropsychiatric Symptoms
- Diffuse midline gliomas with H3 K27 mutations
- Distinguishing Functional Symptoms from Brain Tumors
- EEG and Sleep-Deprivation EEG in Cases of Unclear Neurological Symptoms
- ETMR Tumor Characterization
- Follow-up Observation as a Key Diagnostic Tool
- Immunotherapy for Pediatric Brain Tumors
- Interdisciplinary Diagnostics Riedstadt
- Misdiagnoses of Neuropsychiatric Symptoms in Children
- molecular diagnostics
- Molecular markers for risk stratification
- Molecular subgroups of medulloblastoma
- Molecular subtypes of ependymoma
- MRI of a pediatric brain tumor
- Neurological Examination in Children with Unclear Symptoms
- Neuropediatric Diagnostics
- Oncolytic Virotherapy for Pediatric Brain Tumors
- Pediatric Brain Tumors
- Pediatric Cancer of the Central Nervous System
- Pediatric Neurology in Riedstadt
- Persistent symptoms as a warning sign of CNS tumors
- Proteogenomic Profiles of Pediatric Brain Tumors
- Pseudoprogression during immunotherapy
- Radiomics in Pediatric Neuro-Oncology
- Riedstadt Children's and Adolescent Hospital, Neuro-Oncology
- Riedstadt Clinic for Child and Adolescent Psychiatry
- Sodium MRI Metabolic Tumor Imaging
- Symptom-Based Misdiagnoses in Pediatrics
- Symptoms Without Organic Findings in Children
- Targeted Therapies for Pediatric Gliomas
You May Also Like
- Pediatric Brain Tumors
Psychiatry versus Neuro-Oncology: Diagnostic Pitfalls
- What the latest studies on the entire EF spectrum mean for clinical practice
Heart Failure – The 2026 Evidence Update
- Acute ischemic stroke
Alteplase and Tenecteplase Are on the Same Level
- CKD in People with Type 2 Diabetes: Evidence-Based, Optimized Treatment
SGLT-2 inhibitors and GLP-1 receptor agonists: significant improvement in renal outcomes
- Wearables: screening via smartwatch?
New study on atrial fibrillation in high-risk patients
- Planning a Family, Pregnancy, and Breastfeeding
Update on Anti-Rheumatic Medications
- Peristomal skin health
Focus on preventive care options
- Mental Health with GLP-1 RAs